John J. Marini, M.D. Professor of Medicine, University of Minnesota (USA). He was educated and trained at Johns Hopkins School of Medicine and at the University of Washington. Presently Dr. Marini is a member of numerous editorial boards, an author and editor of 11 medical textbooks, and contributor to more than 350 scientific and educational articles. His investigative work has always concentrated in understanding the cardiopulmonary physiology and management of acute respiratory failure, with an emphasis on defining the mechanisms underlying the patient-ventilator interactions which occur during critical illness. In the majority of that research, he has been positioned at the interface between basic physiology and clinical medicine so as to develop mechanistic insights that advance clinical practice. Refining our understanding of ventilator-induced lung injury is a theme he currently pursues with collaborators at the bench, laboratory, and clinical levels.
Fernando J Martinez is Chief of the Division of Pulmonary and Critical Care Medicine at Weill Cornell Medical College, New York. Prior to this appointment, he was Professor of Internal Medicine and Associate Chief for Clinical Research in the Division of Pulmonary and Critical Care Medicine at the University of Michigan Health System, Ann Arbor, Michigan, as well as Medical Director of its Pulmonary Diagnostic Services and Co-Medical Director of the Lung Transplantation Program. After graduating from the University of Florida School of Medicine, Gainesville, Florida, he completed a residency in internal medicine at Beth Israel Hospital, Boston, Massachusetts, and a fellowship in pulmonary medicine at the Boston University Pulmonary Center. He received a Masters in Biostatistics and Clinical Study Design from the University of Michigan School of Public Health.
Professor Martinez’s main research interests include the biological underpinnings and therapeutic approaches to interstitial lung diseases (ILD) and chronic obstructive pulmonary disease (COPD). He is a member of numerous societies, including the American Thoracic Society (ATS), the European Respiratory Society (ERS), the American College of Chest Physicians, and in the past the Fleischner Society. Previously, he was a member of the ATS Committees which generated guidelines for the management of COPD, respiratory infections, idiopathic pulmonary fibrosis, and cardiopulmonary exercise testing. He is the former Chair of the Clinical Problems Assembly of ATS. Professor Martinez is a member of the GOLD Science Committee and sits on a number of editorial boards, including for Journal of COPD and American Journal of Respiratory and Critical Care Medicine. He serves as the Editor-in-Chief for the latter.
Hiromi Matsubara, MD, PhD, is currently the Deputy Director of National Hospital Organization Okayama Medical Center, Okayama, Japan. After finishing his fellowship at National Cardiovascular Center, Osaka, Japan in 1993. He became an Assistant Professor of Department of Physiology II at Okayama University Graduate School of Medicine and Dentistry. He became an Assistant Professor of Department of Cardiovascular Medicine in 1997 and the Associate Professor in 2000. He then became the Clinical Professor of Department of Cardiovascular Medicine and the Director of Department of Cardiology at Okayama Medical Center.
His investigative interests have focused on clinical and physiologic aspects of pulmonary hypertension. He started balloon pulmonary angioplasty (BPA) for chronic thromboembolic pulmonary hypertension in 2004 and has experienced about 3000 procedures of BPA in more than 500 patients during 19 years. He has made Department of Cardiology at Okayama Medical Center as the largest BPA center in Japan.
Dr. Mehra is a physician scientist, Professor of Medicine of the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University and Director of Sleep Disorders Research focused on investigation of sleep disorders and health outcomes with a focus on cardiopulmonary disease. She has almost 20 years of experience in the conduct of clinical and translational science and leading the Sleep Coordinating Center for multicenter studies. She is Chair of the American Heart Association Statement on Sleep Apnea and Cardiac Arrhythmia, Co-Chair of the NHLBI Autonomic Nervous System Cardiopulmonary Interactions workshop, immediate past Chair of the American Thoracic Society Sleep Respiratory Neurobiology Assembly, Chair of the American Academy of Sleep Medicine Inpatient Diagnostic Sleep Testing Task Force, and Associate Editor of the American Journal of Respiratory and Critical Care Medicine. Dr. Mehra has over 200 publications, delivered >300 lectures and mentored more than 40 trainees
Professor Mohammad Ashkan Moslehi is a board-certified pediatric interventional pulmonologist. He leads the Pediatric Interventional Pulmonology Division at Shiraz University of Medicine Sciences and holds several prestigious positions in international associations. He is an expert in various bronchoscopy techniques and Pleuroscopy among the neonates, infants and children. He is the chairman of the World Association for Bronchial and Interventional Pulmonology (WABIP)-Pediatrics, the Board of Directors of WABIP, the co-founder and vice president of the Asian Association of Pediatric Interventional Pulmonology (APIPA). He has founded the International Association of Pediatric Airway Team (INPAT). He also serves as the chairman of the WABIP Award Committee member, reviewing nominations and award applications for the Killian Centennial Medal, WABIP-Dumon Award, and Heinrich Becker Award for Clinical Research and Innovation.
Dr Naveed Mustfa is a Consultant in Respiratory Medicine at the University Hospital of North Midlands. He is lead for the Midlands Regional Complex Home Ventilation and Weaning Unit. He has been a director the North Midlands Motor Neurone Disease (MND) Research and Care Centre since 2008 that provides care across Staddordshire, Cheshire, Shropshire and part of North Wales.
He performed his research on respiratory muscle weakness and respiratory compliations in MND at King’s College London and completed a PhD and with the team published articles on the effects of non-invasive ventialtion on people with MND and their carers, the effects of cough assist and diaphragm emg recoring with surface electrodes.
He is also an honorary lecturer at Keele University and Medical School.
Dr Mustfa is also the clinical lead for the Bedside Clinical Guideline Partnership (BCGP) producing guidelines for the region and is worling with the Computer Sciences Departments at Keele University and University of Colorado School of Medicine to produce an evdence based guidelines application.
Prof. Jun-Pyo MYONG has carried out the education, research, medical treatment on Occupational and Environmental Medicine in Seoul St. Mary’s Hospital, College of Medicine, the Catholic University of Korea. He also has his sub-special as occupational and environmental respiratory diseases such as pneumoconiosis (Silicosis, Coal Workers’ pneumoconiosis, and asbestosis), Humidifier Disinfectant induced Lung disorder, etc. He has a broad backgrounds for Occupational and Environmental Respiratory diseases, with clinical aspects for Epidemiology, Preventive Medicine, Field Survey, and Big data analysis. As a deputy head of WHO CC for Occupational Health (KOR-09; CIMC), he is participating in many projects with researchers in many countries for occupational and environmental lung disease issues.
Professor Yasutaka Nakano is a physician-scientist. He graduated in medicine from Kyoto University, Japan, and received his medical license. After completing his residency and obtaining board certification in pulmonary medicine, he began his research career. His research focused on the structure-function relationship of lung diseases, and he mainly used computed tomography (CT) data and quantitatively evaluated various parameters of lung structures. He is one of the first to develop software for quantitative evaluation of lung structures. Using the original software, he studied the relationship between lung structural changes and functional changes, including pulmonary function tests, physical constitution, symptoms, prognosis, and so on. Chronic obstructive pulmonary disease (COPD) is his main research target disease, and he proposed the phenotyping of COPD, which has been widely accepted worldwide. He is now a professor of medicine at Shiga University of Medical Science, Japan, and he continues to conduct research vigorously.
Professor Calvin S.H. Ng Professor, Thoracic Surgery
Department of Surgery
The Chinese University of Hong Kong
Dr Ng graduated from Imperial College, London in 1999 with honours, and received his training in cardiothoracic surgery in Hong Kong and UK. He is a pioneer in single port VATS, hybrid operating room image guided surgery, navigation and robotic bronchoscopy, and endobronchial ablation therapies. He is co-PI in NAVABLATE, TARGET, INCITE-ES and POWER studies among others, investigating these technologies. His academic contributions include more than 270 publications in indexed international journals, as well as books and book chapters.
Dr Ng Ziqin studied medicine at Yong Loo Lin School of Medicine, National University of Singapore, and graduated in 2015. She obtained the Membership of the Royal Colleges of Physicians (UK) and Master of Medicine (Singapore) in 2017. Dr Ng is dually accredited as a specialist in both Respiratory Medicine and Intensive Care Medicine. Her passion lies in managing patients with interstitial lung disease (ILD) and believes in providing personalised expert care for her patients. She is currently practising at Tan Tock Seng Hospital in Singapore, where she also runs the ILD service. Dr Ng has publications in both local and international journals. She is also actively involved in educating medical students and is a clinical tutor and teacher in both Yong Loo Lin School of Medicine and Lee Kong Chian School of Medicine respectively.
Dr Joanne Ngeow, BMedSci, MBBS, FRCP, MPH is Senior Consultant, Division of Medical Oncology at the National Cancer Centre Singapore and Associate Professor (Genomic Medicine) at the Lee Kong Chian School of Medicine, Nanyang Technological University Singapore. Dr Ngeow currently heads the Cancer Genetics Service at the National Cancer Centre Singapore with an academic clinical interest in hereditary cancer syndromes and translational clinical cancer genetics. Dr Ngeow is funded by the National Medical Research Council Clinician Scientist Award and Ministry of Health to explore how gene-environmental interactions predisposes to cancer initiation and progression and the implementation of genomics into routine clinical care. Dr Ngeow is one of the Principal Investigators of the Health for Life in Singapore Study (HELIOS), a state-of-the-art multi-ethnic population cohort study.
Yeon-Mok Oh is a professor of medicine at the Department of Pulmonary & Critical Care Medicine, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea. In addition, he is a president of Obstructive Lung Disease Research Foundation in Korea.
Prof. Oh completed his medical degree at the Seoul National University College of Medicine in 1990, and subsequently underwent general internal medicine and pulmonary medicine training at the Seoul National University Hospital. From 2000 to 2002, he had a postdoctoral fellowship at Cardiovascular Research Institute, Univ. California San Francisco, San Francisco, CA, USA. In addition, he was a visiting professor at Division of Pulmonary and Critical Care Medicine, Brigham and Women’s Hospital, Boston, MA, USA. Prof. Oh earned his MS degree from the Seoul National University in 1994, and his PhD in 2006.
Prof. Oh is an authority on the respiratory diseases such as chronic obstructive pulmonary disease (COPD), asthma and bronchiectasis. He is the author of more than 466 publications and the textbook which provides readers with an overview of COPD, the current understanding of its pathobiology, and a contemporary approach to diagnosis and treatment. Moreover, he has actively led the clinical trials for COPD, asthma and bronchiectasis based on clinical big data as the principal investigator.
Rick is a bioinformatician who combines computer science, statistics, population genetics and genomics to develop and apply novel algorithms and software in the research and analysis for pathogenesis and molecular epidemiology of infectious diseases, including monitoring of antimicrobial resistance for public health surveillance. He is currently an Assistant Professor with the Saw Swee Hock School of Public Health at the National University of Singapore.
Professor Hye Yun Park is a member of KATRD (Korean Academy of Tuberculosis and Respiratory Disease) and Korean Association of Internal Medicine. She has been under postdoctoral fellowship in UBC James Hogg Research Center the Institute for Heart and Lung Health in Canada from July 2011 to Sep 2013. She was awarded for Young Scheweitzer Award in 2009, for Best fellow presenter in internal medicine of Samsung medical center in 2010, and for LG future medical researcher in 2013. She has published over 100 SCI(E) articles (publications as first/corresponding author) mostly about COPD and asthma. She serves as the Associate Editor of European Respiratory Journal.
Full Name: Sunghoon Park
Job title: Professor
Institution: Hallym University Sacred Heart Hospital
1992-1998 College of Medicine, Hallym University, Awarded M.D. Degree in Medicine
2000-2002 Graduate School, Hallym University, Awarded M. Msc Degree in
2007-2011 Graduate School, Hallym University, Awarded M. Doc Degree in Medicine
1998-1999: Internship, Hallym University Kangdong Sacred Heart Hospital, Republic of Korea
1999-2003: Residency, Hallym University Kangdong Sacred Heart Hospital, Republic of Korea
2006-2008: Fellowship, Pulmonary and Critical Care Medicine, Samsung Medical Center, Republic of Korea
2008-2013: Assistant Professor, Pulmonary and Critical Care Medicine, Hallym University Sacred Heart Hospital, Republic of Korea
2014 (1 year); Observational fellowship, ECMO program in NYPH/Columbia University Medical Center, New York, U.S.A.
2014-2020: Associated Professor, Pulmonary and Critical Care Medicine, Hallym University Sacred Heart Hospital, Republic of Korea
2021-present: Professor, Pulmonary and Critical Care Medicine, Hallym University Sacred Heart Hospital, Republic of Korea
Member of the Korean Association of Tuberculosis and Respiratory Disease (KATRD)
Board member of committee, The Korean Society of Critical Care Medicine (KSCCM)
Ian D Pavord, MA DM FRCP FERS FMedSci is Professor of Respiratory Medicine at the University of Oxford and Honorary Consultant Physician at the Oxford University Hospitals. He is a member of congregation at the University of Oxford and a Professorial Fellow of St Edmund Hall. He was a Consultant Physician from 1995 and Honorary Professor of Medicine from 2005 to 2013 at the Institute for Lung Health, Glenfield Hospital, University Hospitals of Leicester NHS Trust. He was elected an NIHR Senior Investigator in 2011&14, an inaugural Fellow of the European Respiratory Society in 2014 and a Fellow of the Academy of Medical Science in 2015.
He has a research interest in the clinical aspects of inflammatory airway diseases and has pioneered the use of non-invasive measures of airway inflammation in the assessment of these conditions. He has identified a number of clinically important phenotypes of inflammatory airway disease, has discovered clinically important biomarkers, and has played a lead role in the clinical development of three of the most promising new treatments for severe airway disease.
Professor Pavord was co-editor of Thorax from 2010-2015, Chief Medical Officer of Asthma UK from 2008-14, Associate Editor of the American Journal of Respiratory and Critical Care Medicine from 2005-10 and has been Associate Editor of the European Respiratory Journal since 2016. He is the author of over 550 publications and has an H-index of 123 making him the 2nd highest cited researcher in asthma worldwide. He received the 2016 European Respiratory Society (ERS) Gold Medal for his research and gave the Cournand Lecture at the 2004 ERS meeting. He chaired the 2017 Lancet Commission on asthma.
Before joining NTU as an Associate Professor of Infectious Diseases, Kevin Pethe gained expertise in R&D in the private sector as research investigator at the Novartis Institute for Tropical Disease (Singapore), and at Institut Pasteur Korea (2011-2014) where he held various positions, including head of the department, and acting CEO. He is an expert on infectious diseases, in particular on therapeutics development for difficult to treat bacterial infection such as tuberculosis or non-tuberculous mycobacteria (NTM)
Dr Phan Thu Phuong
Director of Respiratory Center -Bach Mai Hospital
Lecturer of Internal Medicine Deptment – Hanoi Medical University
Vice President of Hanoi Respiratory Society (VNRS)
A/Prof Phan Thu Phuong has the expertise, leadership, training, and motivation necessary to successfully carry out the proposed research project. She has more than 15 years’ experience in pulmonary and critical care, with specific training and expertise in respiratory medicine
She has conducted many studies related to pulmonary disease as a PI or Co-Investigator. She have published 20 chapters and books as an author and co-author printed by Medical Publishing house of Vietnam.
Professor Price is the Founder and Head of the Observational and Pragmatic Research Institute (OPRI) in Singapore, conducting real-life, pragmatic, and observational research, delivering clinical trials and database research across various regions, including the United States, Europe, and the Asia-Pacific area. Additionally, Professor Price is the Head of Optimum Patient Care (OPC) Global in Australia and the UK, a social enterprise focused on disease registries and quality improvement in healthcare. He established the Optimum Patient Care Research Database (OPCRD), which holds data from over 1100 general practices and 19.5 million patients in the UK. Professor Price leads the International Severe Asthma Registry (ISAR) and the Collaboration on Quality Improvement Initiative for Achieving Excellence in Standards of COPD Care (CONQUEST) registries. With over 888 peer-reviewed publications, an H-index of 103, Professor Price specializes in clinical trial design, exploring ways to improve adherence to treatment plans, and understanding patient attitudes towards respiratory diseases.
Dr. Puah Ser Hon is a Senior Consultant Respiratory Physician and Intensivist working in the Respiratory and Critical Care Medicine Department in Tan Tock Seng Hospital where he currently leads as the Head of Department.
He started his career as a House Officer in Queen Elizabeth Hospital in Kota Kinabalu, the main city of the state of Sabah in Malaysia in 2004. He subsequently worked in Tawau General Hospital in the town of Tawau, which is also in Sabah, and eventually went back to Queen Elizabeth Hospital under the Ministry of Health, Malaysia. He joined Tan Tock Seng Hospital in 2011 and was trained both in Respiratory and Intensive Care Medicine. He is also He is also an Adjunct Senior Lecturer in Lee Kong Chian School of Medicine and a Clinical Lecturer for Yong Loo Lin School of Medicine from the National University of Singapore.
He is a keen educator and enjoys teaching. He recently acquired the International Masters of Science in Health Professionals Education from Maastricht University. He was previously the Programme Director for the National Health Group Respiratory Medicine Residency Programme and Clinical Director for the Respiratory Therapist services in Tan Tock Seng Hospital.
He regularly conducts lectures and bedside tutorials for Residents and non-Resident Medical Officers, at the Yong Loo Lin School of Medicine and Lee Kong Chian School of Medicine.
His field of interest includes obstructive airway diseases, bronchiectasis and acute respiratory distress syndrome.
Dr. Hanyu Qin was trained as an intensivist in Peking Union Medical College Hospital, Beijing. Her previous research focused on clinical application of metagenomics in causative microbiome investigation among ventilated patients due to severe pneumonia. Meanwhile, she was interested in sepsis susceptibility and endotypes. She joined Oxford for further training in Statistics on big data, eg. Transcriptomics, Proteomics. Her current project involves primary clustering of host response to severe pneumonia or lung infiltration secondary to all cause sepsis using Olink proteomic assay, effects of immunomodulator intervention at biology level within trials, potential of single cell assay in identifying deleterious neutrophil roles from bronchoalveolar lavage fluid.
Prof. Rhee is a member of editorial board of American Journal of Respiratory and Critical Care Medicine, Journal of COPD, BMC Pulmonary Medicine, Frontiers in Medicine, Journal of Thoracic Disease, Journal of Korean Medical Science, and Life. He is also a Deputy Editor of Tuberculosis and Respiratory Diseases.
Prof. Rhee is a member of long-range planning committee of ERS Assembly 5. He is also a Chairperson of APSR Research Committee, Head of APSR COPD assembly, and a member of Planning and Action Committee on APSR Development. He is a member of steering committee of International Severe Asthma Registry. He is also a member of many committees of Korean Academy of Tuberculosis and Respiratory Disease.
Prof. Rhee has published 250 SCI(E) articles (98 publications as first/corresponding author). The focus of his research is COPD and asthma.
Dr. Rivera joined the University of Rochester in 2022 as the C. Jane Davis & C. Robert Davis Distinguished Professor in Pulmonary Medicine, Chief of the Division of Pulmonary and Critical Care Medicine, and Associate Director of Diversity, Equity, and Inclusion at Wilmot Cancer Center in the University of Rochester Medical Center, Rochester, New York.
Her expertise includes screening, diagnosing, staging lung cancer, and managing treatment complications.
Before moving to Rochester, NY, Dr. Rivera was a Tenured Professor of Medicine in the Pulmonary and Critical Care Medicine Division at Chapel Hill University of North Carolina (UNC). She co-founded the first Multidisciplinary Thoracic Oncology Program in 1995, paving the way for pulmonologists to contribute to the care of lung cancer patients. In 2015 she developed the Multidisciplinary Lung Cancer Screening Program at UNC.
Dr. Rivera Co-developed and Co-directs the North Carolina Lung Screening Registry, a research registry that partners with community and academic imaging sites across the state to generate real-world evidence on the delivery, quality, and outcomes of lung cancer screening. She is an NIH/NCI-funded researcher and collaborates with colleagues at URMC to examine interventions that can improve lung cancer screening rates at URMC and the catchment area.
Throughout her career, Dr. Rivera has held numerous leadership positions in professional societies including Chest, the National Lung Cancer round Table, and the American Thoracic Society.
Dr. Rivera is passionate about teaching, mentoring, and developing the next generation of leaders and increasing the representation of women and underrepresented groups in pulmonary and critical care medicine.
Dr RUAN Wen is a senior consultant with the Department of Cardiology at National Heart Centre Singapore. Her clinical speciality interest is in echocardiography and pulmonary hypertension. She completed her postgraduate MRCP (UK) in 2012. On successfully completed her Advanced Specialty Training in Cardiology in 2015. She received scholarship from Singapore Health Manpower Development Plan and went on further training in pulmonary hypertension in Royal Papworth Hospital in Cambridge, UK in 2018. Since returning to NHCS, she runs a pulmonary hypertension clinic, and is an active member of multidisciplinary pulmonary hypertension team.